Samuel Dagogo-Jack

Samuel E. Dagogo-Jack is a Nigerian-American physician.[1] He is the A.C. Mullins Endowed Professor in Translational Research, Professor of Medicine, and Chief of the Division of Endocrinology, Diabetes, and Metabolism at the University of Tennessee Health Science Center.[2] He is also an Editor of the Journal of Clinical Endocrinology & Metabolism.

He is the director of the Postgraduate Specialist Training Program in Endocrinology, Diabetes, and Metabolism, and of the Clinical Research Unit, Clinical and Translational Research Institute at UTHSC. He was President (Medicine & Science) of the American Diabetes Association in 2015[3] and is a recipient of the Banting Medal for Leadership from the ADA.[4]

Dagogo-Jack earned a medical degree (MBBS) from the University of Ibadan Medical School in Nigeria,[5] was a resident in Internal Medicine and Endocrinology at the Royal Victoria Infirmary, University of Newcastle, UK, and was certified as a member of the Royal College of Physicians. He also earned research degrees of Master of Science at the University of Newcastle and a Doctor of Medicine degree at the University of Ibadan. He additionally had fellowship training in metabolism at Washington University School of Medicine and was a faculty member in the Division of Endocrinology, Diabetes and Metabolism there.

He developed the first radioimmunoassay for an epidermal growth factor (EGF) in human saliva,[6] isolated EGF from mouse thyroid,[7] and worked on the regulation of EGF in mice and humans.[8][9][10][11] His work with Philip E. Cryer led to the discovery of the hypoglycemia-associated autonomic failure syndrome[12] and development of methodology for reversal of hypoglycemia unawareness.[13]